CHI’s Inaugural CMC Strategies for Antibody-Drug Conjugates invites scientists to share their expertise in the areas of regulatory affairs, analytics, process monitoring, process development and manufacturing, and discuss how they have successfully brought an ADC from development to clinical to commercial manufacturing. Synthon will be presenting at this event.

More information on Bioprocessing Summit.


     Share this page